SEC Form 4
Niagen Bioscience, Inc. (NAGE) insider trading
No open-market NAGE insider purchases or sales were filed in the 12 months to Nov 18, 2026.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $0
- 0 filings
Who traded NAGE, and when
NAGE daily close from Nov 18, 2025 to Nov 17, 2026, between $2.01 and $7.04, last $2.04. No open-market insider purchases or sales were filed in this period.
No open-market insider purchases or sales were filed in the last 12 months.
Open-market trades
0 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | ||||||
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | |||||||
GET /stocks/filings/vX/form-4?tickers=NAGE&filing_date.gte=2025-11-18&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CDXC",
"NAGE"
],
"issuer_cik": "0001386570",
"owner_cik": "0001417952",
"accession_number": "0001417952-26-000002",
"form_type": "4",
"filing_date": "2026-07-08",
"period_of_report": "2026-06-30",
"issuer_name": "Niagen Bioscience, Inc.",
"issuer_trading_symbol": "NAGE",
"owner_name": "Fried Robert N",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "holding",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"shares_owned_following_transaction": 95001,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By Fried-Travis Revocable Trust U/A Dated 06/02/1999"
},
{
"tickers": [
"CDXC",
"NAGE"
],
"issuer_cik": "0001386570",
"owner_cik": "0001417952",
"accession_number": "0001417952-26-000002",
"form_type": "4",
"filing_date": "2026-07-08",
"period_of_report": "2026-06-30",
"issuer_name": "Niagen Bioscience, Inc.",
"issuer_trading_symbol": "NAGE",
"owner_name": "Fried Robert N",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "holding",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"shares_owned_following_transaction": 250000,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020",
"footnotes": [
{
"id": "F2",
"description": "The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 4 records
- Option exercises1 record
- Grants and awards3 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Niagen Bioscience, Inc.'s CEO sold stock?
No. Robert N. Fried (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is NAGE’s insider data?
These are NAGE Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track NAGE insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for NAGE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.